Market Tracker

04/28 12:12pm ET

SPDR® S&P Biotech ETF (XBI)

BATS BZX Real-Time Price
As of 10:25am ET
 -5.90 / -2.67%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

The Trader Daily
7:07am /
How to Invest Money in Biotech
Apr 19 /
The Trader Daily
Apr 27 /


1 month+0.78% 3 years+39.96%
3 months+8.23% 5 years+30.75%
1 year+79.82% Since inception+18.00%
Data through 04/28/2015

Quote Details

Previous close$220.94
Open day’s range211.46 – 224.48
Net asset value (NAV)221.11 (04/27/2015)
Daily volume787,898
Average volume (3 months)833,194
Data as of 10:25am ET, 04/28/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+30.75%+22.89%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio1.191.48
Net assets$2.2B$1.8B
Average market cap$2.2B$35.3B
Average P/E--25.2
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
PRTA Prothena Corporation PLC1.40%
ASPX Auspex Pharmaceuticals Inc1.34%
ESPR Esperion Therapeutics Inc1.31%
FOLD Amicus Therapeutics Inc1.24%
INO Inovio Pharmaceuticals Inc1.22%
IMGN ImmunoGen Inc1.20%
ALDR Alder Biopharmaceuticals Inc1.20%
OREX Orexigen Therapeutics Inc1.17%
RCPT Receptos Inc1.16%
KPTI Karyopharm Therapeutics Inc1.15%